Biblio
“Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1027-1040, 2018.
, “The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic Patients.”, J Alzheimers Dis, vol. 55, no. 2, pp. 679-689, 2017.
, “Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1477-1487, 2017.
, “Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort.”, J Alzheimers Dis, vol. 52, no. 3, pp. 875-85, 2016.
,